| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |